Combination therapy for lymphoproliferative diseases
US6316435A · kind A · utility
10Cited by
0References
49Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 1999 |
| Grant date | Nov 13, 2001 |
| Priority date | — |
| Expiry date | Feb 24, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods and kits for treating lymphoproliferative diseases in a host including (co)administering to the host pentostatin, at least one alkylating agent and at least one methylated xanthine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.